Skip to main content

FDA: Authorizations of Emergency Use of Certain Drug and Biological Products During the COVID-19 Pandemic; Availability

Federal Register
Feb 19, 2021
The Food and Drug Administration (FDA) announces five Emergency Use Authorizations for drugs and biological products for use during the COVID-19 pandemic. These authorizations are effective on their date of issuance.
Tagged as
Infectious diseases · Pharmacy and prescription drugs · Policy